Skip to main content

Silexion Therapeutics Corp PRE 14A, filed Sep 25, 2026

Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Corp shareholders will vote on adding 500,000,000 authorized shares and authorizing a reverse split between 1-for-15 and 1-for-25 to restore Nasdaq compliance with $1.00 minimum bid price and $2.5 million shareholders’ equity requirements. AI summary

PRE 14A 2026-09-25 For: 2026-09-25
View Original
Added on October 18, 2026